Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC
GMED — Globus Medical, Inc.
EXPENSIVE (MOS -27.4%) · Quality 64/100
Price
74.08
Intrinsic value
58.17
Margin of safety
-27.4%
Implied growth (reverse DCF)
+3.3%
model assumes +0.0%
Value Score
23.5
Quality
64
Psychology
16.1
Discovery
18.4
price/volume attention only
Moat score
22
erosion: watch
Value Score: bottom 23% of Russell 3000 · Quality: bottom 46%
Open the interactive Deep Dive for GMED →
Use this data programmatically
This page's numbers are also available as JSON at /api/v1/deep-dive/GMED - see the API docs for the full read-only surface, including an MCP server for AI assistants.
Common questions
Is GMED undervalued?
As of 2026-09-19, GMED trades at 74.08 against a computed intrinsic value of 58.17 (-27.4% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.
What is Globus Medical, Inc.'s Value Score?
Globus Medical, Inc.'s Value Score is 23.5 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.